Books > Business & Economics > Business & management
|
Buy Now
Science, the State and the City - Britain's Struggle to Succeed in Biotechnology (Hardcover)
Loot Price: R1,866
Discovery Miles 18 660
|
|
Science, the State and the City - Britain's Struggle to Succeed in Biotechnology (Hardcover)
Expected to ship within 12 - 17 working days
|
The book examines the evolution of one of the most important
technologies that has emerged in the last fifty years:
biotechnology - the use of living organisms, or parts thereof to
create useful products and services. The most important application
of biotechnology has been in medicine, in the development of new
drugs. The central purpose of the book is to explain how firms
based in the US took the lead in commercialising the technology,
and why it has been so difficult for firms in other countries to
match what the leading American companies have achieved. The book
looks at the institutions and policies which have underpinned US
success in biotechnology. This is the US innovation "ecosystem,"
and it is made up of several interlocking elements which constitute
a powerful competitive advantage for US biotechnology firms. These
include, a higher education system which has close links with
industry, massive support from the Federal government for
biomedical research, and a financial system which is well equipped
to support young entrepreneurial firms in a science-based industry.
In the light of US experience the book examines in detail the
performance of UK biotechnology firms over the past forty years,
starting with the creation of the UK's first dedicated biotech
firm, Celltech, in 1980. The book shows how the UK made a promising
start in the 1980s and 1990s but failed to build on it. Several
leading firms failed, and after an initial burst of enthusiasm
investors lost confidence in the British biotech sector. It is only
the last few years that the sector has staged a revival, attracting
fresh investment from the US as well from the UK. The story told in
this book, based on extensive interviews with industry
participants, investors, and policy makers in the UK, Continental
Europe, and the US, sheds new light on one of the central issues
facing governments in the advanced industrial countries - how to
create and sustain new science-based industries.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.